Page last updated: 2024-09-04

2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and pheophytin a

2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a has been researched along with pheophytin a in 1 studies

Compound Research Comparison

Studies
(2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a)
Trials
(2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a)
Recent Studies (post-2010)
(2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a)
Studies
(pheophytin a)
Trials
(pheophytin a)
Recent Studies (post-2010) (pheophytin a)
695395,28553,625

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dubey, S; Ethirajan, M; Liu, TH; Missert, J; Morgan, J; Pandey, RK; Pandey, SK; Shibata, M; Srivatsan, A; Zheng, X1

Other Studies

1 other study(ies) available for 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a and pheophytin a

ArticleYear
Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy.
    Molecular pharmaceutics, 2011, Aug-01, Volume: 8, Issue:4

    Topics: Cell Line, Tumor; Chlorophyll; Chlorophyll A; Chromatography, High Pressure Liquid; Humans; Integrin alphaVbeta3; Magnetic Resonance Spectroscopy; Molecular Structure; Oligopeptides; Photochemotherapy; Photosensitizing Agents

2011